Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
RSC Medicinal Chemistry|September 11, 2025
Bicyclic temporin L peptide inhibitors targeting the SARS-CoV-2 main protease: design, synthesis, <i>in vitro</i> inhibition efficiency and molecular dynamics insightsMd Taimuzzaman Sharif, Md Omor Farque, Md Habibur Rahaman, et al.Vaccine: X|May 30, 2024
Investigation of the vaccine potential of an <i>in silico</i> designed FepA peptide vaccine against <i>Shigella flexneri</i> in mice modelMd Rayhan Ali, Shahin Mahmud, Md Omar Faruque, et al.Biomed Research International|February 17, 2015
Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stabilityVinojini B Nair, Ross A D Bathgate, Frances Separovic, et al.Frontiers in Chemistry|May 2, 2022
Evaluation of Potential DnaK Modulating Proline-Rich Antimicrobial Peptides Identified by Computational ScreeningThomas N G Handley, Wenyi Li, Nicholas G Welch, et al.The Journal of Biological Chemistry|August 23, 2018
Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptorLilian L L Wong, Daniel James Scott, Mohammed Akhter Hossain, et al.The Biochemical Journal|January 31, 2009
Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin frameworkLinda M Haugaard-Jönsson, Mohammed Akhter Hossain, Norelle L Daly, et al.Behavioural Brain Research|February 6, 2013
Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the ratPhilip J Ryan, Elena Büchler, Fazel Shabanpoor, et al.ACS Medicinal Chemistry Letters|November 20, 2020
Effects of C-Terminal B-Chain Modifications in a Relaxin 3 Agonist AnaloguePraveen Praveen, Julien Tailhades, K Johan Rosengren, et al.Biochemical and Biophysical Research Communications|March 20, 2012
Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormoneFazel Shabanpoor, Ross A D Bathgate, Alessia Belgi, et al.Journal of the American Academy of Dermatology|July 20, 2007
Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin colorLaura A G Armas, Susan Dowell, Mohammed Akhter, et al.Pageof 15